慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停重叠综合征的研究进展
收稿日期: 2022-05-24
网络出版日期: 2023-05-15
基金资助
国家自然科学基金项目(NSFC 81770085);国家自然科学基金项目(82070095);上海市静安区卫生科研课题(2020MS20)
Research progress on the overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnoea
沈宏华, 许轶明, 张音, 任蕾, 陈锐 . 慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停重叠综合征的研究进展[J]. 内科理论与实践, 2023 , 18(02) : 111 -116 . DOI: 10.16138/j.1673-6087.2023.02.010
| [1] | Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717. |
| [2] | Arnardottir ES, Bjornsdottir E, Olafsdottir KA, et al. Obstructive sleep apnoea in the general population: highly prevalent but minimal symptoms[J]. Eur Respir J, 2016, 47(1): 194-202. |
| [3] | Flenley DC. Sleep in chronic obstructive lung disease[J]. Clin Chest Med, 1985, 6(4): 651-661. |
| [4] | Shawon MS, Perret JL, Senaratna CV, et al. Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease[J]. Sleep Med Rev, 2017, 32: 58-68. |
| [5] | Soler X, Gaio E, Powell FL, et al. High prevalence of obstructive sleep apnea in patients with moderate to severe chronic obstructive pulmonary disease[J]. Ann Am Thorac Soc, 2015, 12(8): 1219-1225. |
| [6] | Naranjo M, Willes L, Prillaman BA, et al. Undiagnosed OSA may significantly affect outcomes in adults admitted for COPD in an inner-city hospital[J]. Chest, 2020, 158(3): 1198-1207. |
| [7] | Silva JLR Júnior, Conde MB, Corrêa KS, et al. Sleep-disordered breathing in patients with COPD and mild hypoxemia: prevalence and predictive variables[J]. J Bras Pneumol, 2017, 43(3): 176-182. |
| [8] | 沈久成, 孙丽, 王婧, 等. 阻塞性睡眠呼吸暂停对慢性阻塞性肺疾病患者心肺功能的影响[J]. 中华医学杂志, 2021, 101(22): 1665-1670. |
| [9] | McNicholas WT. Impact of sleep in COPD[J]. Chest, 2000, 117(2 Suppl): 48S-53S. |
| [10] | Tuleta I, St?ckigt F, Juergens UR, et al. Intermittent hypoxia contributes to the lung damage by increased oxidative stress, inflammation, and disbalance in protease/antiprotease system[J]. Lung, 2016, 194: 1015-1020. |
| [11] | Dewan NA, Nieto FJ, Somers VK. Intermittent hypoxemia and OSA: implications for comorbidities[J]. Chest, 2015, 147(1): 266-274. |
| [12] | Zhang XL, Gao B, Han T, et al. Moderate-to-severe obstructive sleep apnea and cognitive function impairment in patients with COPD[J]. Int J Chron Obstruct Pulmon Dis, 2020, 27(15): 1813-1822. |
| [13] | Rodrigues F, Papoila AL, Ligeiro D, et al. Acute exercise amplifies inflammation in obese patients with COPD[J]. Rev Port Pneumol (2016), 2006, 22(6): 315-322. |
| [14] | Wan N, Tang X, Ding H, et al. Influence of coexistence of mild OSA on airway mucus hypersecretion in patients with COPD[EB/J]. J Breath Res, 2021.https://doi.org/10.1088/1752-7163/abd52e. |
| [15] | Wang Y, Hu K, Liu K, et al. Obstructive sleep apnea exacerbates airway inflammation in patients with chronic obstructive pulmonary disease[J]. Sleep Med, 2015, 16(9): 1123-1130. |
| [16] | Macrea M, Campbell S, Martin T, et al. The peripheral neutrophils in subjects with COPD-OSA overlap syndrome and severe comorbidities: a feasible inflammatory biomarker?[J]. Adv Clin Exp Med, 2018, 27(12): 1677-1682. |
| [17] | Krishnan V, Dixon-Williams S, Thornton JD. Where there is smoke—there is sleep apnea: exploring the relationship between smoking and sleep apnea[J]. Chest, 2014, 146(6): 1673-1680. |
| [18] | Yang X, Tang X, Cao Y, et al. The bronchiectasis in COPD-OSA overlap syndrome patients[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15: 605-611. |
| [19] | McNicholas WT. COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management[J]. Chest, 2017, 152(6): 1318-1326. |
| [20] | Poulain M, Doucet M, Major GC, et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies[J]. CMAJ, 2006, 174(9): 1293-1299. |
| [21] | Messineo L, Lonni S, Magri R, et al. Lung air trapping lowers respiratory arousal threshold and contributes to sleep apnea pathogenesis in COPD patients with overlap syndrome[J]. Respir Physiol Neurobiol, 2020, 271: 103315. |
| [22] | Lee CH, Sethi R, Li R, et al. Obstructive sleep apnea and cardiovascular events after pereutaneous coronary intervention[J]. Circulation, 2016, 133(21): 2008-2017. |
| [23] | Papachatzakis I, Velentza L, Zarogoulidis P, et al. Comorbidities in coexisting chronic obstructive pulmonary di-sease and obstructive sleep apnea-overlap syndrome[J]. EurRev Med Pharmacol Sci, 2018, 22(13): 4325-4331. |
| [24] | 阻塞性睡眠呼吸暂停与卒中诊治专家共识写作组. 阻塞性睡眠呼吸暂停与卒中诊治专家共识[J]. 中华内科杂志, 2014, 53(8): 657-664. |
| [25] | Khurana S, Ravi A, Sutula J, et al. Clinical characteristics and airway inflammation profile of COPD persistent sputum producers[J]. Respir Med, 2014, 108(12): 1761-1770. |
| [26] | Unnikrishnan D, Jun J, Polotsky V. Inflammation in sleep apnea: an update[J]. Rev Endocr Metab Disord, 2015, 16(1): 25-34. |
| [27] | Adir Y, Humbert M, Chaouat A. Sleep-related breathing disorders and pulmonary hypertension[J]. Eur Respir J, 2021, 57(1): 2002258. |
| [28] | Adler D, Bailly S, Benmerad M, et al. Clinical presentation and comorbidities of obstructive sleep apnea-COPD overlap syndrome[J]. PLoS One, 2020, 15(7): e0235331. |
| [29] | Fitzgibbons CM, Goldstein RL, Gottlieb DJ, et al. Physical activity in overlap syndrome of COPD and obstructive sleep apnea: relationship with markers of systemic inflammation[J]. J Clin Sleep Med, 2019, 15(7): 973-978. |
| [30] | Vitacca M, Paneroni M, Braghiroli A, et al. Exercise capacity and comorbidities in patients with obstructive sleep apnea[J]. J Clin Sleep Med, 2020, 16(4): 531-538. |
| [31] | Trimer R, Zangrando KL, et al. Overlap syndrome: the coexistence of OSA further impairs cardio respiratory fitness in COPD[J]. Sleep Breath, 2020, 24(4): 1451-1462. |
| [32] | Kennedy K, Corby C, Noctor E. Manic-like presentation with an organic aetiology[J]. Ir J Psychol Med, 2020, 7: 1-4. |
| [33] | Economou NT, Ilias I, Velentza L, et al. Sleepiness, fatigue, anxiety and depression in chronic obstructive pulmonary disease and obstructive sleep apnea-overlap-syndrome, before and after continuous positive airways pressure therapy[J]. PLoS One, 2018, 13(6):e0197342. |
| [34] | Olaithe M, Bucks RS, Hillman DR, et al. Cognitive deficits in obstructive sleep apnea: insights from a meta-review and comparison with deficits observed in COPD, insomnia, and sleep deprivation[J]. Sleep Med Rev, 2018, 38: 39-49. |
| [35] | Singh S, Kaur H, Singh S, et al. The overlap syndrome[J]. Cureus, 2018, 10(10): e3453. |
| [36] | Ustun B, Westover MB, Rudin C, et al. Clinical prediction models for sleep apnea: the importance of medical history over symptoms[J]. J Clin Sleep Med, 2016, 12(2):161-168. |
| [37] | Soler X, Liao SY, Marin JM, et al. Age, gender, neck circumference, and Epworth sleepiness scale do not predict obstructive sleep apnea (OSA) in moderate to severe chronic obstructive pulmonary disease(COPD)[J]. PLoS One, 2017, 12(5): e0177289. |
| [38] | Nagappa M, Liao P, Wong J, et al. Validation of the STOP-bang questionnaire as a screening tool for obstructive sleep apnea among different populations[J]. PLoS One, 2015, 10(12): e0143697. |
| [39] | Marti-Soler H, Hirotsu C, Marques-Vidal P, et al. The NoSAS score for screening of sleep disordered breathing: a derivation and validation study[J]. Lancet Respir Med, 2016, 4(9): 742-748. |
| [40] | 陈安书, 汪柯馨, 应珂璐, 等. 关于美国胸科协会对慢性阻塞性肺疾病合并睡眠呼吸障碍的病理生理学主要问题的官方声明的解读[J]. 世界临床药物, 2022, 43(3):226-232. |
| [41] | Singh S, Khan SZ, Singh D, et al. The uses of overnight pulse oximetry[J]. Lung India, 2020, 37(2): 151-157. |
| [42] | Braghiroli A, Sacco C, Erbetta M, et al. Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure[J]. Am Rev Respir Dis, 1993, 48(1): 173-178. |
| [43] | Dragonieri S, Quaranta VN, Carratu P, et al. Exhaled breath profiling in patients with COPD and OSA overlap syndrome[J]. J Breath Res, 2016, 10(4): 041001. |
| [44] | Dumitrache-Rujinski S, C?lc?ianu G, Bogdan M. Devices used in non-invasive ventilation for obstructive sleep apnea associating COPD and/or morbid obesity[J]. Pneumologia, 2013, 62(2): 106-109. |
| [45] | Stanchina ML, Welicky LM, Donat W, et al. Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome[J]. J Clin Sleep, 2013, 9(8): 767-772. |
| [46] | Singh G, Agarwal A, Zhang W, et al. Impact of PAP therapy on hospitalization rates in medicare beneficiaries with COPD and coexisting OSA[J]. Sleep Breath, 2019, 23(1): 193-200. |
| [47] | Lacedonia D, Carpagnano GE, Aliani M, et al. Daytime PaO2 in OSAS, COPD and the combination of the two (overlap syndrome)[J]. Respir Med, 2013, 107(2): 310-316. |
| [48] | Toraldo DM, De Nuccio F, Nicolardi G. Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study[J]. Sleep Breath, 2010, 14(2): 115-123. |
| [49] | Kuklisova Z, Tkacova R, Joppa P, et al. Severity of nocturnal hypoxia and daytime hypercapnia predicts CPAP failure in patients with COPD and obstructive sleep apnea overlap syndrome[J]. Sleep Med, 2017, 30(1): 139-145. |
| [50] | Carlucci A, Ceriana P, Mancini M, et al. Efficacy of bilevel-auto treatment in patients with obstructive sleep apnea not responsive to or intolerant of continuous positive airway pressure ventilation[J]. J Clin Sleep Med, 2015, 11(9): 981-985. |
| [51] | Kuklisova Z, Tkacova R, Joppa P, et al. Severity of nocturnal hypoxia and daytime hypercapnia predicts CPAP failure in patients with COPD and obstructive sleep apnea overlap syndrome[J]. Sleep Med, 2017, 30: 139-145. |
| [52] | Su M, Huai D, Cao J, et al. Auto-trilevel versus bilevel positive airway pressure ventilation for hypercapnic overlap syndrome patients[J]. Sleep Breath, 2018, 22(1): 65-70. |
| [53] | Ioachimescu OC, Janocko NJ, Ciavatta MM, et al. Obstructive lung disease and obstructive sleep apnea (OLDOSA) cohort study[J]. J Clin Sleep Med, 2020, 16(2):267-277. |
| [54] | Dumitrache-Rujinski S, Croitoru A, Bogdan MA. Therapeutical approach in severe exacerbation of COPD associating obstructive sleep apnoea and obesity[J]. Pneumologia, 2012, 61(2): 117-119. |
| [55] | Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary[J]. Arch Bronconeumol, 2017, 53(3): 118-149. |
| [56] | Paneroni M, Colombo F, Papalia A, et al. Is telerehabilitation a safe and viable option for patients with COPD?[J]. COPD, 2015, 12(2): 217-225. |
| [57] | Sengul YS, Ozalevli S, Oztura I, et al. The effect of exercise on obstructive sleep apnea: a randomized and controlled trial[J]. Sleep Breath, 2011, 15(1): 49-56. |
| [58] | 杜井波, 沈宏华, 许轶明, 等. 慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停重叠综合征特点分析及康复疗效[J]. 内科理论与实践, 2020, 15(1): 31-37. |
| [59] | Limsuwat C, McClellan R, Amiri HM, et al. Pulmonary rehabilitation improves only some domains of health-related quality of life measured by the short form-36 questionnaire[J]. Ann Thorac Med, 2014, 9(3): 144-148. |
| [60] | Loredo JS, Ancoli-Israel S, Kim EJ, et al. Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea[J]. Sleep, 2006, 29(4): 564-571. |
| [61] | Biselli PJ, Kirkness JP, Grote L, et al. Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study[J]. J Appl Physiol (1985), 2017, 122(1): 82-88. |
| [62] | McNicholas WT, Coffey M, Boyle T. Effects of nasal airflow on breathing during sleep in normal humans[J]. Am Rev Respir Dis, 1993, 147(3): 620-623. |
| [63] | McGinley BM, Patil SP, Kirkness JP, et al. A nasal cannula can be used to treat obstructive sleep apnea[J]. Am J Respir Crit Care Med, 2007, 176(2): 194-200. |
| [64] | Sarber KM, Chang KW, Epperson MV, et al. Hypoglossal nerve stimulation in veterans with obstructive sleep apnea[J]. Laryngoscope, 2020, 130(9): 2275-2280. |
| [65] | Poulain M, Doucet M, Major GC, et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies[J]. CMAJ, 2006, 174(9): 1293-1299. |
| [66] | Vanfleteren LE, Beghe B, Andersson A, et al. Multimorbidity in COPD, does sleep matter?[J]. Eur J Intern Med, 2020, 73: 7-15. |
/
| 〈 |
|
〉 |
